This study investigated the potentiation of KSeCN for both antimicrobial blue light (aBL,405nm) and antimicrobial photodynamic inactivation (aPDI) against different species of Gram-negative bacteria. For planktonic (108CFU/ml) E.coli, with KSeCN treatment (50mM concentration and 60J/cm2 aBL) demonstrated an increase of 4- to 5-log10 CFU reduction compared to aBL alone. E. coli, with KSeCN treatment (50mM,100uM Verteporfin and 20J/cm2 aBL) demonstrated an increase of 4- to 6-log10 CFU reduction compared to aPDI (100uM concentration of Verteporfin and 20J/cm2 aBL, 30min incubation time) alone. K. Pneumoniae and A. Baumannii show similar results. For biofilm (106 CFU/mL), an obvious CFU reduction of 5- to 7-log10 could be seen with KSeCN treatment (50mM and 100J/cm2 aBL) compared to aBL alone. CFU reduction of 6.5- to 8-log10 could be seen with KSeCN treatment (50mM,100uM Verteporfin and 40J/cm2 aBL) compared to aPDI alone (100uM concentration of Verteporfin and 40J/cm2). Confocal results (live/dead) made these findings solid which highlight the KSeCN function to potentiate aBL and aPDI against G-bacteria, offering a novel approach for antibiotic resistance infections.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.